Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
09/2010
09/07/2010US7790207 Methods to inhibit the formation of colouring components and to reduce the presence of materials tending to form colouring components to obtain a lighter and less yellow canola protein isolate
09/07/2010US7790202 functions as a sunscreen, an anti-perspirant, an insect/pest repellant and/or an antiseptic; zinc oxide powder, peppermint powder, basil powder, rosemary powder, eucalyptus powder, copper mica powder, and silica powder spheres
09/07/2010US7790201 non-coated complex particulate comprising ion consisting of a styrene-divinylbenzene sulfonic acid cationic exchange resin and a pharmaceutically active material such as oxycodone hydrochloride, tramadol hydrochloride complexed with ion exchange resin; avoids use of coatings and large amounts of solvents
09/07/2010US7790198 Preparation and administration form comprising an acid-labile active compound
09/07/2010US7790196 method for in vitro and/or ex vivo transferring molecule of interest to eukaryotic cell comprising step of:contacting eukaryotic cell with non-pathogenic amoeba Dictyostelium discoideum vesicle that contains a molecule of interest, under conditions sufficient to allow vesicle to fuse with eukaryotic cell
09/07/2010US7790194 Combining acrylamide and methylene bis-acrylamide, adding radical initiatiator and washing with pyrogen-free water or saline solution; for lip augmentation/reconstruction
09/07/2010US7790189 Triple helical oligonucleotide comprising polysaccharide carrier and unmethylated CpG motif for use as DNA vaccine in treatment of infection and metabolic disorders
09/07/2010US7790180 Attenuated rotavirus population comprising a single variant or substantially a single variant which is defined by a nucleotide sequence encoding at least one of the major viral proteins designated as VP4 and VP7; diarrhea therapy
09/07/2010US7790179 Attenuated rotavirus population comprising a single variant or substantially a single variant which is defined by a nucleotide sequence encoding at least one of the major viral proteins designated as VP4 and VP7; diarrhea therapy
09/07/2010US7790177 Immunizing compositions comprising recombinant attenuated self-replicating viral RNA replicons encoding an epitope obtained from the HIV-1 matrix protein myrstate binding site
09/07/2010US7790168 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
09/07/2010US7790167 Vaccine efficiency using immunology stimulants
09/07/2010US7790162 Compositions and uses thereof for identifying and targeting provasopressin-expressing cancer cells
09/07/2010US7790150 acetal resin or ketone polymer conjugate; drug covalently attached to polymer via succinamide linkages; the succinamidoester is oriented such that an ester is formed at the carrier side while the carboxyl forms amide bond with an amine-containing drug; glycine link; drug delivery; camptothecin CPT, Taxol
09/07/2010US7790145 Bioactive material in perforated microstructure; propellant suspension; mixture of bronchodilator and antiinflammatory agent
09/07/2010US7790140 Carrier with a metal binding domain, a metal ion, and an active agent; e.g., polylysine with a polyoxyethylene side chain with a polyalkylenepolyaminepolyacetic acid bonded to a transition metal ion bonded to a protein or nucleotide; drug delivery
09/07/2010CA2488248C Film-shaped, dissolvable preparations for active substance release and method for the production thereof
09/07/2010CA2457401C Transdermal therapeutic system containing fentanyl or related substances
09/07/2010CA2457245C Transdermal therapeutic system (tts) containing the active substance fentanyl
09/07/2010CA2431188C Pharmaceutical compositions enhancing the immunogenicity of poorly immunogenic antigens
09/07/2010CA2429650C Oral pharmaceutical compositions containing cyclodextrins as taste masking agent
09/07/2010CA2406229C Anti-sepsis conjugate vaccine
09/07/2010CA2368676C Sphingomyelin containing preparation
09/07/2010CA2351273C Solution of n-[o-(p-pivaloyloxybenzenesulfonylamino) benzoyl] glycine monosodium salt tetra-hydrate and drug product thereof
09/07/2010CA2334615C Production process for polymeric micelle charged therein with drug and polymeric micelle composition
09/07/2010CA2259156C Truncated soluble tumor necrosis factor type-i and type-ii receptors
09/02/2010WO2010099552A2 Devices, systems and methods for magnetic-assisted therapeutic agent delivery
09/02/2010WO2010099542A2 Formulations of atp and analogas of atp
09/02/2010WO2010099200A1 Oligomer-amino acid conjugates
09/02/2010WO2010098627A2 Pharmaceutical preparation
09/02/2010WO2010098625A2 Pharmaceutical preparation
09/02/2010WO2010098482A1 Stable capsule preparation and method for producing same
09/02/2010WO2010098442A1 Carbon monoxide removal agent
09/02/2010WO2010098433A1 Coenzyme q10-containing composition for oral ingestion
09/02/2010WO2010098432A1 Immunogenic composition
09/02/2010WO2010098417A1 Magnesium oxide fine granules
09/02/2010WO2010098265A1 Polymeric micelle containing proteasome inhibitor
09/02/2010WO2010098230A1 Transdermal preparation
09/02/2010WO2010098103A1 Equol-producing bacterium and use thereof
09/02/2010WO2010097700A1 Bendamustine cyclopolysaccharide compositions
09/02/2010WO2010097643A1 Formulation based on micronized zeolite, green tea extract, and genistein as a therapeutic agent for reduction of body weight and cellulite
09/02/2010WO2010097434A1 Process for the preparation of cyclodextrins composed of more than eight glucose units
09/02/2010WO2010077853A3 Mono- and di-peg il-10 production; and uses
09/02/2010WO2010056065A9 Method for preparing microspheres and microspheres produced thereby
09/02/2010WO2010023670A3 Methods for covalently attaching a polymer to a methionine residue in proteins and peptides
09/02/2010US20100222419 Method to inhibit cell growth using oligonucleotides
09/02/2010US20100222390 Methods and Compositions for the Intravenous Administration of Compounds Related to Proton Pump Inhibitors
09/02/2010US20100222314 Aqueous-based Pharmaceutical Composition
09/02/2010US20100222305 Complexes of phosphate derivatives
09/02/2010US20100222288 Stabilized Formulation of Ivermectin Feed Premix with an Extended Shelf Life and Method of Making the Same
09/02/2010US20100222220 Compositions of particulate coformulation
09/02/2010US20100221808 Polysialic acid derivatives
09/02/2010US20100221331 Pharmaceutical compositions comprising colloidal silicon dioxide
09/02/2010US20100221318 Nucleic acids for inhibiting hairless protein expression and methods of use thereof
09/02/2010US20100221305 Formulations for coated microprojections containing non-volatile counterions
09/02/2010US20100221292 Injection molding process for the preparation of an oral delivery device for the pharmaceutically active agent
09/02/2010US20100221234 Bone delivery conjugates and method of using same to target proteins to bone
09/02/2010US20100221213 Y-shape branched hydrophilic polymer derivatives, their preparation methods, conjugates of the derivatives and drug molecules, and pharmaceutical compositions comprising the conjugates
09/02/2010US20100221184 Compositions for Delivery of Therapeutics and Other Materials
09/02/2010CA2753753A1 Devices, systems and methods for magnetic-assisted therapeutic agent delivery
09/02/2010CA2753641A1 Bendamustine cyclopolysaccharide compositions
09/02/2010CA2753567A1 Immunogenic composition
09/02/2010CA2753426A1 Coenzyme q10-containing composition for oral ingestion
09/02/2010CA2753316A1 Magnesium oxide granules
09/02/2010CA2753103A1 Equol-producing bacterium and use thereof
09/01/2010EP2223942A1 Process for the preparation of cyclodextrins composed of more than eight glucose units
09/01/2010EP2223703A1 External preparation composition comprising fatty acid-based ionic liquid as active ingredient
09/01/2010EP2223702A1 Core particle for pharmaceutical preparation
09/01/2010EP2223685A1 Non-gelatin enteric hard capsule shell and preparation method thereof
09/01/2010EP2223683A1 Oral powder and granular antitumor agent
09/01/2010EP2223682A1 Stable pharmaceutical solution formulations for pressurised metered dose inhalers
09/01/2010EP2222757A2 Supramolecular handcuffs in polymeric architecture
09/01/2010EP2222754A2 Thermoresponsive arginine-based hydrogels as biologic carriers
09/01/2010EP2222714A2 Polysaccharide gel compositions and methods for sustained delivery of drugs
09/01/2010EP2222340A1 Nanoemulsions
09/01/2010EP2222339A2 Use of avicins to deliver therapeutic and diagnostic agents
09/01/2010EP2222329A1 Modified recombinant factor viii and von willebrand factor and methods of use
09/01/2010EP2222328A1 Method of administering conjugates
09/01/2010EP2222287A2 Multitarget compounds active at a ppar and cannabinoid receptor
09/01/2010EP2222278A1 Improved taxane delivery system
09/01/2010EP2222277A1 Pegylated liposomal formulations for photodynamic treatment of inflammatory diseases
09/01/2010EP1962806B1 Pre-compacted calcium-containing compositions
09/01/2010EP1629105B1 Compositions for enhancing transport and antisense efficacy of nucleic acid analog into cells
09/01/2010EP1472211B1 Emollients and cosmetic compositions
09/01/2010EP1423406B1 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
09/01/2010EP1372727B1 Biodegradable carrier and method for preparation thereof
09/01/2010CN1523997B Stabilized interleukin 2
09/01/2010CN1401391B Use of casein and polypeptide in Chinese herbal medicine/Chinese patent medicine
09/01/2010CN101821369A Process for producing highly purified orange roughy oil
09/01/2010CN101821317A Method for manufacturing linear polyethylenimine (pei) for transfection purpose and linear pei obtained with such method
09/01/2010CN101821281A Glycoproteins and glycosylated cells and method for the preparation of the same
09/01/2010CN101820920A Novel conjugated proteins and peptides
09/01/2010CN101820919A Injectable polymer-lipid blend for localized drug delivery
09/01/2010CN101820918A Novel taxoid-based compositions
09/01/2010CN101820917A Aqueous ophthalmic formulations
09/01/2010CN101820916A Compositions comprising sphingosine 1 phosphate (s1p) receptor modulators
09/01/2010CN101820913A Immunoliposome inducing apoptosis into cell expressing death domain-containing receptor
09/01/2010CN101820893A Granular jelly beverage for medication and process for producing the same
09/01/2010CN101820877A Agent for fungal dermatitis
09/01/2010CN101820864A Nucleic acid-lipopolymer compositions
1 ... 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 ... 1712